Author: Julian Braun; Lucie Loyal; Marco Frentsch; Daniel Wendisch; Philipp Georg; Florian Kurth; Stefan Hippenstiel; Manuela Dingeldey; Beate Kruse; Florent Fauchere; Emre Baysal; Maike Mangold; Larissa Henze; Roland Lauster; Marcus Mall; Kirsten Beyer; Jobst Roehmel; Juergen Schmitz; Stefan Miltenyi; Marcel A Mueller; Martin Witzenrath; Norbert Suttorp; Florian Kern; Ulf Reimer; Holger Wenschuh; Christian Drosten; Victor M Corman; Claudia Giesecke-Thiel; Leif-Erik Sander; Andreas Thiel
Title: Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors Document date: 2020_4_22
ID: 164yx77a_14
Snippet: Recent studies on SARS-CoV-2 serology have raised the question whether antibody studies are 140 sufficient to identify individuals with mild or asymptomatic courses of COVID-19 7,10 or 141 whether additional, cellular signatures are needed to identify acute or past infections. Here, we 142 assessed additional activation marker profiles on S-reactive T cells from COVID-19 patients. 143.....
Document: Recent studies on SARS-CoV-2 serology have raised the question whether antibody studies are 140 sufficient to identify individuals with mild or asymptomatic courses of COVID-19 7,10 or 141 whether additional, cellular signatures are needed to identify acute or past infections. Here, we 142 assessed additional activation marker profiles on S-reactive T cells from COVID-19 patients. 143
Search related documents:
Co phrase search for related documents- antibody study and SARS serology: 1, 2, 3, 4, 5, 6, 7, 8, 9
- individual identify and SARS serology: 1, 2
- past acute infection and SARS serology: 1
- past acute infection identify and SARS serology: 1
- recent study and SARS serology: 1
Co phrase search for related documents, hyperlinks ordered by date